New Delhi – November 21, 2026: Inaugurating an international conclave on metabolic epidemiology and genetic science, Union Minister of State for Science and Technology Dr. Jitendra Singh stated that India is rapidly establishing itself as the world’s preeminent research hub for diabetes, human genomics, and precision diagnostics.
Dr. Singh pointed out that the successful completion and clinical validation of the ‘Genome India’ reference database has furnished Indian scientists with unprecedented genomic data specifically tailored to the diverse genetic architecture of the subcontinent. This foundational bio-computational resource enables researchers to decipher ethnic susceptibility markers for Type-2 diabetes, cardiovascular anomalies, and rare genetic disorders, shifting the national healthcare paradigm from reactive therapeutics to individualized preventative precision care.
The Minister highlighted that India’s biotechnology sector, bolstered by public-private scientific partnerships and AI-driven pharmacological screening pipelines, is developing affordable point-of-care bio-sensors and indigenous genomic assays. These breakthroughs promise to lower the cost of advanced diagnostic molecular testing from thousands of dollars to accessible local price points.
He urged young computational biologists and clinical researchers to spearhead indigenous clinical trials, asserting that India’s vast bio-repository combined with high-performance computing capabilities will anchor the future of global medical discovery.
Published by True Roots Media

